Yoga for Adolescent and Young Adult Non-Curative Cancer Patients
- Conditions
- Advanced Cancer
- Interventions
- Behavioral: Hatha Yoga
- Registration Number
- NCT01901237
- Lead Sponsor
- Rob Rutledge
- Brief Summary
Adolescents and young adults who are living with cancer are not benefiting from the same age-appropriate physical and psychosocial care, as are children and older adults. As a result, their unique needs often go unmet or unaddressed. Studies have demonstrated that a lack of age-appropriate care may be responsible for a deceased quality of life. Studies have also shown that physical activity is able to reduce many of the negative side-effects linked to cancer and its treatment (e.g., nausea, vomiting, fatigue). A light form of physical activity that is both safe and manageable for cancer patients is yoga. The purpose of this study is to examine the achievability and safety of a light 7-week home/hospice-based Hatha yoga program (available on DVD) in the adolescent and young adult non-curative cancer population. This study will also examine the ability of yoga to reduce cancer related side effects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5
- Diagnosed with a non-curative cancer and assigned to non-curative or palliative care
- Between 15-39 years of age
- Have primary physician/oncologist consent to participate
- Experience any medical conditions that contraindicate yoga (e.g., bone metastases)
- Exhibit cognitive limitations (e.g., psychiatric disorders)
- Score below 30% on Palliative Performance Status Scale
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Hatha Yoga Program Hatha Yoga Single-arm pilot study of a 7-week home/hospice-based Hatha yoga program for adolescent and young adults with non-curative cancer.
- Primary Outcome Measures
Name Time Method Feasibility: Recruitment Final: end of week 7 Recruitment will be calculated by the number of patients who consent to participate, divided by the number of eligible participants recommended by the primary oncologist/physician.
Feasibility: Retention Final: end of week 7 Retention: Will be determined by reporting the number of participants who complete the baseline and post-program questionnaire and follow-up testing.
Feasibility: Adherence Final: end of week 7 Adherence: Participants will be asked to record the number of yoga sessions performed each week. Overall adherence will be calculated by summing the actual number of sessions the participant engaged in, divided by the recommended number of sessions.
Safety Final: end of week 7 Safety: Any adverse events reported by the participant will be recorded.
- Secondary Outcome Measures
Name Time Method Changes in Quality of Life Baseline: week 1; Final: week 7 Participants will be asked to complete the Functional Assessment of Chronic Illness Therapy - Palliative Care subscale (FACIT-Pal) and the Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being subscale (FACIT-Sp) at baseline and post-intervention.
Trial Locations
- Locations (1)
Dalhousie University
🇨🇦Halifax, Nova Scotia, Canada